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Parenteral nutrition (PN) is the intravenous provi-sion of nutrients to patients in whom enteral feed-ing is insufficient or contraindicated. PN may be 
provided via a central or peripheral vein and may be used 
as stand-alone nutrition support or as an adjunct to 
enteral nutrition. In adults, common indications for PN 
include inflammatory bowel disease, ischemic bowel, 
radiation enteritis, bowel obstruction, motility disorders, 
and many others.1 In children, common indications 
include prematurity, necrotizing enterocolitis, pancreati-
tis, and short bowel syndrome.1 Patients who are acutely 
ill or require short-term PN typically receive PN as a 
24-hour continuous infusion. In stable patients who are 
expected to have a longer course of PN or receive treat-
ment at home, PN is often administered on a cyclic (dis-
continuous) schedule.
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Cyclic PN infusion is more convenient than continu-
ous infusion for patients and families. Daily stopping of 
the infusion temporarily frees patients from infusion 
equipment for participation in school, work, and social 
activities. However, PN is needed for nutrition support 
and is also associated with development of metabolic 
complications with substantial morbidity and mortality 
(eg, hepatobiliary dysfunction).2-4 It is therefore impor-
tant that nutrition support clinicians recognize the meta-
bolic consequences of cyclic infusion so the practical 
benefits of cyclic infusion may be weighed against the 
potential risks. This review was done to synthesize the 
available clinical data describing the metabolic effects of 
cyclic PN infusion.
Methods
A literature search was conducted through PubMed 
(1948 to December 2009) and MEDLINE (1950 to 
third week of November 2009) using the search term 
parenteral nutrition plus any of the following: cycling, 
cycle, cyclic, discontinuous, intermittent, bolus. Relevant 
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publications and their references cited were reviewed for 
inclusion. Original English-language reports of prospec-
tive clinical studies characterizing the metabolic effects 
of cyclic PN infusion in humans were included in the 
review. This included studies comparing cyclic infusion 
with continuous infusion, studies comparing the cyclic 
infusion period with the noninfusion period, and studies 
investigating the metabolic effects of initiation and dis-
continuation of infusions. Studies published only in 
abstract form and studies exclusively investigating con-
tinuous sequential infusion methods were not included. 
No attempt was made to pool study data for analysis. 
Pooled analysis was not considered based on high inter-
study variability in sample selection, study protocol, and 
data reporting.
Results
Studies and Level of Evidence
A total of 25 publications met the specified criteria and 
were included in the final literature review. Of these, 10 
used a randomized parallel-group or crossover design 
(n = 5-65), 11 used a before–after or nonrandomized 
crossover design (n = 4-48), and 4 used a nonrandomized 
parallel-group design (n = 8-10). None used blinding.
Nutrient Utilization
Protein metabolism and nitrogen balance. Several small 
studies have consistently demonstrated similar nitrogen 
balance achieved with continuous and cyclic PN infusion 
(N = 5-14).5-10 Comparable nitrogen balance was also 
achieved in a randomized parallel-group study of 16 trau-
matized or infected mechanically ventilated patients.11 In 
27 malnourished patients, 3 days of continuous infusion 
followed by cyclic infusion significantly improved nitrogen 
balance.12 Two studies using this technique also demon-
strated increases in serum albumin levels (N = 14, 27, 
respectively).8,12 However, a randomized controlled trial of 
patients with a history of hepatobiliary dysfunction showed 
no differences in serum albumin levels with cyclic infu-
sion compared with continuous infusion (N = 65).13 Four 
patients with corticosteroid-induced hypercatabolism who 
switched to cyclic PN infusion following a period of con-
tinuous infusion had lower nitrogen balance with cyclic 
infusion in 1 study.9
Two randomized parallel-group studies of sequential 
bolus infusion, a method in which nutrition is supplied 
in a series of six 1-hour infusions daily, showed higher 
nitrogen balance compared with continuous infusion 
in patients following cholecystectomy (N = 30)14 but 
lower nitrogen balance in patients following major sur-
gery (N = 65).15
Carbohydrates, fat, and respiratory quotient. Two before–
after studies showed higher blood glucose concentrations 
during the infusion period compared with the noninfu-
sion period of cyclic PN regimens, with a quick return to 
baseline values following discontinuation of PN infusion 
(N = 15, 4, respectively).16,17 Two studies, one of which 
was a randomized crossover study, demonstrated similar 
rates of carbohydrate (CHO) and fat oxidation between 
cyclic and continuous PN infusions during infusion per 
nonprotein respiratory quotient (RQ; N = 5, 8).6,10 During 
the postinfusion period of cyclic PN, CHO oxidation 
decreased and fat oxidation increased.6,10 There was net 
lipogenesis and nonprotein RQ > 1 during infusion, com-
pared with net lipolysis and nonprotein RQ < 1 following 
discontinuation.6,10 Hepatic triglyceride secretion was not 
affected by infusion schedule in a randomized parallel-
group study (N = 22)18 nor was nighttime oxygen con-
sumption in a small nonrandomized parallel-group study 
(N = 8).19 A randomized parallel-group study of 16 trau-
matized or infected patients requiring mechanical ventila-
tion demonstrated greater increases in O2 uptake and 
CO2 elimination with initiation of cyclic PN infusion 
compared with continuous infusion.11 Changes in RQ 
with PN were similar between groups.
Energy expenditure. In 3 studies, of which 2 used a ran-
domized crossover design, daily energy expenditure was 
similar with cyclic and continuous PN infusion (N = 
5-12).6,7,10 Energy expenditure increased during infusion 
of cyclic PN regimens and decreased during the noninfu-
sion period, whereas it remained relatively constant 
throughout the day with continuous infusion.6,7,10 
Sequential bolus infusion resulted in lower overall energy 
balance following cholecystectomy in a randomized 
parallel-group study (N = 30).14 In a randomized parallel-
group study of 16 traumatized or infected patients requir-
ing mechanical ventilation, energy expenditure increased 
when patients began cyclic or continuous PN infusions; 
however, the increases were greater in the cyclic vs con-
tinuous infusion group.11 These greater increases in 
energy expenditure were accompanied by greater thermo-
genic and body temperature responses but similar heart 
rates and blood pressures.
Hormones, catecholamines, and circadian rhythms. A num-
ber of before–after studies demonstrated a rapid increase 
in serum insulin concentrations upon PN infusion initia-
tion, with a rapid decrease following discontinuation (N = 
4-48).5,16,17,20 Two of these studies demonstrated similar 
circulating glucagon, cortisol, and growth hormone con-
centrations between patients receiving cyclic and continu-
ous PN infusion (N = 10, 48, respectively).5,20 In a 
randomized parallel-group study of 16 traumatized or 
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infected mechanically ventilated patients, urinary epi-
nephrine, norepinephrine, and cortisol excretion rates 
were similar between patients given cyclic and continuous 
infusion, although circulating cortisol concentrations 
were elevated relative to baseline during infusion of cyclic 
regimens.11 One small study demonstrated circadian 
rhythms of serum levels of total proteins, total cholesterol, 
high- and low-density lipoproteins, triglycerides, free fatty 
acids, and apolipoproteins A and B during cyclic PN 
(N = 6).21
Hepatic Complications
Adults. One randomized parallel-group study of patients 
with a history of hepatobiliary dysfunction during PN 
treatment showed stabilization of serum levels of total and 
direct bilirubin, alkaline phosphatase, serum glutamic 
oxaloacetic transaminase (SGOT), and serum glutamic 
pyruvic transaminase (SGPT) if cyclic PN infusion was 
initiated when total serum bilirubin was <20 mg/dL (N = 
65).13 Among patients randomly assigned to receive con-
tinuous infusion, patients with baseline serum total biliru-
bin levels of 5-10 mg/dL developed increased serum levels 
of total bilirubin, direct bilirubin, and alkaline phospha-
tase; patients with baseline serum total bilirubin levels of 
10-20 mg/dL developed increased serum levels of total 
bilirubin, direct bilirubin, SGOT, and SGPT. No benefit of 
cyclic PN infusion was seen in patients with baseline 
serum total bilirubin levels >20 mg/dL. A study in which 
14 patients were switched to cyclic PN infusion following 
a period of continuous infusion demonstrated significant 
decreases in serum levels of alkaline phosphatase and lac-
tate dehydrogenase with the cyclic regimen and nonsig-
nificant decreases in serum levels of bilirubin and SGOT.8 
These changes were anecdotally noted to occur with 
remittance of hepatomegaly and decreases in hepatic infil-
tration of glycogen and fat seen on serial biopsy.
Children. One study of 10 infants stabilized on continu-
ous PN infusion, and subsequently switched to cyclic 
infusion, showed an increase in serum bilirubin levels in 
the 2 weeks prior to cycling, with a nonsignificant decease 
in the 2 weeks following cycling initiation.22 In a study of 
10 neonates receiving PN as a series of three 4-hour infu-
sions daily, no patients experienced elevations in serum 
SGOT or SGPT levels during treatment, and 1 patient had 
elevation of direct bilirubin; 18% of historical controls 
developed cholestatic jaundice, 61% developed elevated 
serum SGOT, and 46% developed elevated serum SGPT.23
Glycemic Control
Adults. Abrupt initiation of PN infusion was shown to 
cause blood glucose elevation, primarily in the first 60 
minutes of infusion, in a before–after study (N = 18).24 
Four studies examining the safety of abruptly discontinu-
ing PN infusion in adults showed transient decreases in 
blood glucose, primarily in the first hour following infu-
sion discontinuation, without symptomatic hypoglycemia 
(N = 12-48).20,24-26 Based on the results of a randomized 
crossover study, abrupt discontinuation and tapered dis-
continuation of PN infusion are associated with similar 
responses in blood insulin, glucagon, epinephrine, nor-
epinephrine, cortisol, and growth hormone in the first 90 
minutes following discontinuation (N = 12).25
Children. Abrupt PN discontinuation in 15 children 2.4-
11.4 years old led to no symptomatic hypoglycemia in a 
before–after study.16 A randomized crossover study of 10 
patients 1.5-36 months old showed significantly greater 
decreases in blood glucose levels with abrupt discontinu-
ation compared with tapered discontinuation and higher 
rates of hypoglycemia (55% vs 20%, P value not reported).27
Metabolic Bone Disease
Two studies demonstrated increased urinary calcium, 
magnesium, and phosphorus excretion during cyclic PN 
infusion, in 1 case relative to the noninfusion period 
(N = 16)28 and, in the other, relative to excretion levels 
during continuous infusion (as measured in a historical 
cohort, N = 10).29 However, no differences between cyclic 
and continuous infusion in 24-hour renal filtered calcium 
load, fractional calcium excretion, or blood concentra-
tions of calcium, phosphorus, magnesium, or 25-hydroxy 
vitamin D were observed.29
Discussion
A total of 25 clinical studies met inclusion criteria for 
review. Sample sizes ranged from 4 to 65, with 18 of 25 
studies examining ≤20 patients and 9 of 25 studies exam-
ining ≤10 patients. Ten studies used randomized designs, 
and several others appropriately applied a before–after 
design to investigate short-term metabolic changes in 
individuals upon initiation or discontinuation of infusion. 
In 4 studies, changes in metabolic parameters were 
reported in the context of a before–after design in which 
an earlier continuous infusion regimen was transitioned 
to a later cyclic infusion regimen.8,12,17,22 Although patients 
were stabilized to varying degrees prior to initiation of 
cyclic infusion in these studies, the course of disease over 
time could confound the relationship between infusion 
regimen and metabolic parameter, drawing into question 
any inferences about the impact of infusion schedule. In 
other studies, comparison to a historical control,23,29 use 
of nonrandomized treatment assignments,10,19 and pool-
ing of patients receiving sequential infusion regimens 
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with cyclic infusion patients8 had a similar impact on 
interpretability. Fortunately, none of these studies has 
major treatment implications in the absence of further 
confirmatory data.
Cyclic and continuous PN infusions produce similar 
nitrogen balance in most patients. Sequential bolus infu-
sion of PN produced improved nitrogen balance in an 
initial study, but the technique has not been widely 
researched or adopted in clinical practice. Carbohydrate 
and lipid metabolism are similar with cyclic or continuous 
infusion during infusion. During the postinfusion period 
of cyclic PN regimens, carbohydrate metabolism 
decreases, fat metabolism increases, and RQ decreases. 
Nonprotein RQ decreases between the infusion and non-
infusion states, generally from >1 to <1. In traumatized 
or infected mechanically ventilated patients, cyclic infu-
sion may be disadvantageous because of an increase in 
carbon dioxide production. Circulating concentrations of 
counterregulatory hormones are similar with cyclic and 
continuous PN infusion regimens.
Patients with hyperbilirubinemia receiving continu-
ous PN infusion may experience stabilization in liver 
function tests with a switch to cyclic PN infusion. This 
benefit may not extend to patients with precycling serum 
bilirubin levels of ≥20 mg/dL. Further prospective evi-
dence of benefit from cyclic PN infusion with respect to 
hepatobiliary complications in adults is anecdotal. One 
prospective study in infants who were switched from con-
tinuous to cyclic PN infusion demonstrated stabilization 
and possible decreases in serum bilirubin levels with ini-
tiation of cyclic PN infusion.
Abrupt initiation of cyclic PN infusion may lead to 
transient hyperglycemia in some patients. Abrupt discon-
tinuation of cyclic PN infusion in adults has not been 
associated with symptomatic hypoglycemia and has shown 
no impact on hormone and catecholamine responses to 
infusion termination. In children, abrupt discontinuation 
of PN infusion is most likely to cause hypoglycemia in 
patients younger than 2-3 years old, whereas older chil-
dren have shown similar results to adults.
Although data are limited, cyclic PN infusion has not 
been associated with increased daily losses of calcium, 
phosphorus, magnesium, or vitamin D compared with 
continuous infusion. Although calcium loss increases 
during cyclic PN infusion, there is little evidence that this 
could contribute to metabolic bone disease.
Conclusion
Clinical data support the current widespread use of cyclic 
PN infusion in most populations. Although practicality is 
the primary impetus for cyclic PN infusion and likely its 
greatest benefit, clinical studies have played an important 
role in confirming that the modality is generally not 
metabolically disadvantageous. Some benefit may be real-
ized in prevention of hepatobiliary disease, but some 
precautions must be taken to avoid hypoglycemia, par-
ticularly in young children. Acutely ill mechanically ven-
tilated patients may experience increased carbon dioxide 
production with cyclic PN infusion and therefore may 
derive greater benefit from continuous infusion.
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